dAVP [2746]



dAVP


SMILES NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O
InChIKey NFLWUMRGJYTJIN-UHFFFAOYSA-N
Sequence XYFQNCPRG
HELM PEPTIDE1{[*C(=O)CCS* |$_R2;;;;;;_R3$|].(Y,[dY]).(F,[dF]).(Q,[dQ]).(N,[dN]).(C,[dC]).(P,[dP]).(R,[dR]).G.[am]}$PEPTIDE1,PEPTIDE1,1:R3-6:R3$$$V2.0

Chemical Properties

Hydrogen bond acceptors 15
Hydrogen bond donors 13
Rotatable bonds 19
Log P -4.342
Molecular weight (Da) 1068.4
Stereochemistry info unspecified


No bioactivity data available.

dAVP


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.